These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15962836)

  • 41. Decreased glomerular proteinase activity in the streptozotocin diabetic rat.
    Song RH; Singh AK; Leehey DJ
    Am J Nephrol; 1999; 19(3):441-6. PubMed ID: 10393385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy.
    Tomohiro T; Kumai T; Sato T; Takeba Y; Kobayashi S; Kimura K
    Life Sci; 2007 Mar; 80(15):1364-72. PubMed ID: 17331548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress.
    Lv S; Cheng J; Sun A; Li J; Wang W; Guan G; Liu G; Su M
    Diabetes Res Clin Pract; 2014 Apr; 104(1):143-54. PubMed ID: 24513119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altering expression of alpha3beta1 integrin on podocytes of human and rats with diabetes.
    Chen HC; Chen CA; Guh JY; Chang JM; Shin SJ; Lai YH
    Life Sci; 2000 Sep; 67(19):2345-53. PubMed ID: 11065181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes.
    Tang Z; Shou I; Wang LN; Fukui M; Tomino Y
    Nephron; 1997; 76(3):323-30. PubMed ID: 9226234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical characterization of glomerular PDGF B-chain and PDGF beta-receptor expression in diabetic rats.
    Nakagawa H; Sasahara M; Haneda M; Koya D; Hazama F; Kikkawa R
    Diabetes Res Clin Pract; 2000 May; 48(2):87-98. PubMed ID: 10802145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of simvastatin on oxidative stress in streptozotocin-induced diabetic rats: a role for glomeruli protection.
    Zhu B; Shen H; Zhou J; Lin F; Hu Y
    Nephron Exp Nephrol; 2005; 101(1):e1-8. PubMed ID: 15886498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.
    Duggan KA; Hodge G; Makarious MM; Charlesworth JA
    Clin Sci (Lond); 1998 May; 94(5):511-6. PubMed ID: 9682674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypertension accelerates diabetic nephropathy in Wistar fatty rats, a model of type 2 diabetes mellitus, via mitogen-activated protein kinase cascades and transforming growth factor-beta1.
    Imai G; Satoh T; Kumai T; Murao M; Tsuchida H; Shima Y; Ogimoto G; Fujino T; Kobayashi S; Kimura K
    Hypertens Res; 2003 Apr; 26(4):339-47. PubMed ID: 12733703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
    Wysocki J; Ye M; Khattab AM; Fogo A; Martin A; David NV; Kanwar Y; Osborn M; Batlle D
    Kidney Int; 2017 Jun; 91(6):1336-1346. PubMed ID: 27927599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy.
    Sanai T; Sobka T; Johnson T; el-Essawy M; Muchaneta-Kubara EC; Ben Gharbia O; el Oldroyd S; Nahas AM
    Diabetologia; 2000 Jan; 43(1):91-100. PubMed ID: 10663221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Silymarin regulates the cytochrome P450 3A2 and glutathione peroxides in the liver of streptozotocin-induced diabetic rats.
    Malekinejad H; Rezabakhsh A; Rahmani F; Hobbenaghi R
    Phytomedicine; 2012 May; 19(7):583-90. PubMed ID: 22445624
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of renal disease on glomerular proteinases.
    Teschner M; Schaefer RM; Paczek L; Heidland A
    Miner Electrolyte Metab; 1992; 18(2-5):92-6. PubMed ID: 1465087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
    Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
    Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
    Babazono T; Kapor-Drezgic J; Dlugosz JA; Whiteside C
    Diabetes; 1998 Apr; 47(4):668-76. PubMed ID: 9568702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Doxazosin prevents proteinuria and glomerular loss of heparan sulfate in diabetic rats.
    Jyothirmayi GN; Alluru I; Reddi AS
    Hypertension; 1996 May; 27(5):1108-14. PubMed ID: 8621204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.